(Circulation. 1999;100:988-998.)
© 1999 American Heart Association, Inc.
Clinical Cardiology: New Frontiers |
Primary Prevention of Coronary Heart Disease
Integrating Risk Assessment With Intervention
From the Center for Human Nutrition and the Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center at Dallas.
Correspondence to Scott M. Grundy, MD, PhD, Center for Human Nutrition and the Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235-9052.
Key Words: coronary disease • risk factors • prevention
 |
Introduction |
|---|
The concept that coronary heart disease (CHD) can be prevented has increasingly become a driving force in cardiovascular medicine. For many years, the field gave lip service to prevention but neglected to take it seriously. The possibility of effective prevention was met with skepticism from many quarters. Gradually, however, the tide has turned, and prevention is getting the upper hand. Widespread acceptance of the benefits of prevention came first in the area of secondary prevention, ie, preventing recurrent coronary events in patients with established CHD.1 Secondary prevention stands at the boundary between prevention and treatment. Many cardiologists consider secondary prevention to be treatment of coronary artery disease; others see it as prevention of recurrent coronary events. There is a more uniform agreement that prevention of new-onset CHD should be called primary prevention. This article examines some of the major issues currently under scrutiny for primary prevention of CHD. Without question, the area of primary prevention is complex and contentious; some of the issues will not be easily resolved. However, if the burden of CHD in industrialized and developing societies is to be substantially reduced, effective strategies for primary prevention must be put in place.
|
Medical Prevention of Acute Coronary Syndromes |
|---|
Major advances have recently been made in understanding the pathogenesis of acute coronary syndromes (unstable angina, myocardial infarction, and coronary death). Of great importance was the recognition that rupture of vulnerable plaques leading to coronary thrombosis accounts for most acute coronary syndromes.2 3 Equally important was the discovery that the risk of plaque rupture and its consequences
This article has been cited by other articles:
 |
|
 |
|
  J. P. Fisher, A. Kim, C. N. Young, S. Ogoh, P. B. Raven, N. H. Secher, and P. J. Fadel Influence of ageing on carotid baroreflex peak response latency in humans J. Physiol., November 15, 2009; 587(22): 5427 - 5439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koskinen, M. Kahonen, J. S.A. Viikari, L. Taittonen, T. Laitinen, T. Ronnemaa, T. Lehtimaki, N. Hutri-Kahonen, M. Pietikainen, E. Jokinen, et al. Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study Circulation, July 21, 2009; 120(3): 229 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. D'Agostino Sr, R. S. Vasan, M. J. Pencina, P. A. Wolf, M. Cobain, J. M. Massaro, and W. B. Kannel General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study Circulation, February 12, 2008; 117(6): 743 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Eichinger, N. M. Pecheniuk, G. Hron, H. Deguchi, M. Schemper, P. A. Kyrle, and J. H. Griffin High-Density Lipoprotein and the Risk of Recurrent Venous Thromboembolism Circulation, March 27, 2007; 115(12): 1609 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Willich, K. Wegscheider, M. Stallmann, and T. Keil Noise burden and the risk of myocardial infarction Eur. Heart J., February 1, 2006; 27(3): 276 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Deguchi, N. M. Pecheniuk, D. J. Elias, P. M. Averell, and J. H. Griffin High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men Circulation, August 9, 2005; 112(6): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Vasan, L. M. Sullivan, P. W.F. Wilson, C. T. Sempos, J. Sundstrom, W. B. Kannel, D. Levy, and R. B. D'Agostino Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors Ann Intern Med, March 15, 2005; 142(6): 393 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Eilat-Adar, M. Eldar, and U. Goldbourt Association of Intentional Changes in Body Weight with Coronary Heart Disease Event Rates in Overweight Subjects Who Have an Additional Coronary Risk Factor Am. J. Epidemiol., February 15, 2005; 161(4): 352 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Rodriguez-Artalejo and J R Banegas Banegas Cardiovascular epidemiology and prevention J Epidemiol Community Health, February 1, 2004; 58(2): 116 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Redberg, G. T. Kondos, A. Sevrukov, S. S. Devries, E. V. Chomka, J. A. Hoff, M. L. Daviglus, D. B. Garside, and K. Liu Coronary Artery Calcium and Cardiac Events * Response Circulation, December 23, 2003; 108 (25): e167 - e168. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Greenland and J. M. Gaziano Selecting Asymptomatic Patients for Coronary Computed Tomography or Electrocardiographic Exercise Testing N. Engl. J. Med., July 31, 2003; 349(5): 465 - 473. [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Pasternak, J. Abrams, P. Greenland, L. A. Smaha, P. W. F. Wilson, and N. Houston-Miller Task force #1--identification of coronary heart disease risk: is there a detection gap? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1863 - 1874. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grundy, G. L. Vega, M. E. McGovern, B. R. Tulloch, D. M. Kendall, D. Fitz-Patrick, O. P. Ganda, R. S. Rosenson, J. B. Buse, D. D. Robertson, et al. Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes: Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial Arch Intern Med, July 22, 2002; 162(14): 1568 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pfeffer, A. Keech, F. M. Sacks, S. M. Cobbe, A. Tonkin, R. P. Byington, B. R. Davis, C. P. Friedman, and E. Braunwald Safety and Tolerability of Pravastatin in Long-Term Clinical Trials: Prospective Pravastatin Pooling (PPP) Project Circulation, May 21, 2002; 105(20): 2341 - 2346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wayhs, A. Zelinger, and P. Raggi High coronary artery calcium scores pose an extremely elevated risk for hard events J. Am. Coll. Cardiol., January 16, 2002; 39(2): 225 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan, J. M. Massaro, P. W.F. Wilson, S. Seshadri, P. A. Wolf, D. Levy, and R. B. D'Agostino Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart Study Circulation, January 1, 2002; 105(1): 48 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenland, S. C. Smith Jr, and S. M. Grundy Improving Coronary Heart Disease Risk Assessment in Asymptomatic People: Role of Traditional Risk Factors and Noninvasive Cardiovascular Tests Circulation, October 9, 2001; 104(15): 1863 - 1867. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Grundy Coronary calcium as a risk factor: role in global risk assessment J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1512 - 1515. [Full Text] [PDF]
|
|
|
|
|
|
R. Haberl, A. Becker, A. Leber, A. Knez, C. Becker, C. Lang, R. Bruning, M. Reiser, and G. Steinbeck Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients J. Am. Coll. Cardiol., February 1, 2001; 37(2): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.C.W. Van den Hoogen, J.C. Seidell, A. Menotti, and D. Kromhout Blood pressure and long-term coronary heart disease mortality in the Seven Countries Study: implications for clinical practice and public health Eur. Heart J., October 2, 2000; 21(20): 1639 - 1642. [PDF]
|
|
|
|
 |
|
 F. W. Booth, S. E. Gordon, C. J. Carlson, and M. T. Hamilton Waging war on modern chronic diseases: primary prevention through exercise biology J Appl Physiol, February 1, 2000; 88(2): 774 - 787. [Abstract] [Full Text] [PDF]
|
|